| Autor: |
André, Camille, Wu, Kelvin J.Y., Myers, Andrew G., Bispo, Paulo J.M. |
| Zdroj: |
Journal of Global Antimicrobial Resistance; December 2024, Vol. 39 Issue: 1 p144-148, 5p |
| Abstrakt: |
•New synthetic lincosamides, iboxamycin and cresomycin, display potent in vitroactivity against ocular methicillin-resistant Staphylococcus aureus(MRSA) isolates.•Both drugs are active against widespread MRSA clonal complexes CC8 and CC5.•The in vitropotencies of iboxamycin and cresomycin are not impacted by multidrug-resistance phenotypes or by the presence of ermgenes when compared with clindamycin. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect